K-numberK243239
Device nameLung AI (LAI001)
ApplicantExo, Inc.
Product codeMYN
Device classClass II
Decision dateApr 24, 2025
DecisionSubstantially Equivalent
Regulation892.2070
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Lung AI is a computer-aided detection (CADe) software tool that analyzes lung ultrasound cine clips to assist healthcare professionals in detecting consolidation/atelectasis and pleural effusion. It is an adjunctive tool that alerts users to regions of interest (ROIs) on ultrasound images from the PLAPS point using the BLUE protocol. The device is intended for use by trained emergency department physicians and does not provide diagnosis or replace standard clinical care.

Technological characteristics

Lung AI uses supervised deep learning with convolutional neural networks for segmentation, landmark detection, and classification of ultrasound images. Unlike the predicate device (Lung-CAD), which analyzes digital X-ray images, Lung AI processes multi-frame ultrasound cine clips. Both devices use artificial intelligence as a concurrent reading aid for trained professionals on adult patients, but Lung AI is designed specifically for ultrasound modality in emergency departments rather than chest radiography.

Test standards cited

IEC 62304:2006/AC:2015 (Medical device software – Software life cycle processes). The FDA guidances cited include Content of Premarket Submissions for Device Software Functions, Computer-Assisted Detection Devices Applied to Radiology Images and Radiology Device Data, Clinical Performance Assessment for CAD Devices, and Cybersecurity in Medical Devices.

Substantial equivalence argument

Lung AI is substantially equivalent because it shares the same intended use (adjunctive CADe tool for trained healthcare professionals in adult point-of-care settings) and the same principle of operation (supervised deep learning artificial intelligence) as the predicate Lung-CAD. Although the modality differs (ultrasound vs. X-ray), both devices perform similar detection functions with comparable performance metrics. Bench testing on 465 lung scans achieved sensitivity of 0.97 and specificity of 0.91-0.94, and MRMC clinical validation with six emergency physicians demonstrated statistically significant improvements in reader performance (AUC improvements of 0.028-0.035), meeting the acceptance criteria. The device does not raise new safety or effectiveness questions when used as intended.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →